Tag Archives: Malawi becomes associate member of WHO drug safety monitoring programme

Malawi becomes associate member of WHO drug safety monitoring programme

Malawi becomes associate member of WHO drug safety monitoring programme Malawi’s first pharmacovigilance centre was established at the College of Medicine in Blantyre, the country’s financial centre. “As Malawi was not a member of the global drug safety monitoring community we have relied on data from other countries. Realising the disparities that may exist in the side effects that… Read More »